the GXI and GXII platforms provide size, quantification, and purity analysis of discrete fragments of nucleic acids and proteins in the sample. In a potential sequencing workflow, the LabChip DS is used for the initial concentration analysis of extracted genomic DNA. The genomic DNA would then be sheared using third party equipment, then size fractionated on a Caliper LabChip XT platform. Quality control analysis of the sheared DNA and constructed libraries would then be performed using the LabChip GXI platform to assess size, purity and amount of the DNA fragments.
In addition, preparation of samples for the LabChip DS platform can be performed on Caliper's liquid handling instruments, including the Sciclone® NGS Workstation, which is a robust, scalable platform that has been specifically customized for next generation sequencing methods, or Caliper's Zephyr® Genomics Workstation, which automates a broad range of standard molecular biology kits.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
About Trinean
Trinean, a spin-off from the University of Ghent and IMEC, Belgium, is a pioneer in automated micro volume spectroscopy systems. Trinean's first product is the DropSense®96, a multichannel spectrophotometer, that combined with disposable m
'/>"/>
SOURCE Caliper Life Sciences, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences2.
Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program3.
Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation4.
Caliper Life Sciences to Present at UBS Global Life Sciences Conference5.
Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays6.
Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice7.
Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line8.
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs9.
Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results10.
Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling11.
Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results